Literature DB >> 830808

Transient amaurosis under decreased atmospheric pressure with sphenoidal sinus dysplasia. Case report.

K Sugita, T Hirota, I Iguchi, N Kageyama, A Ito.   

Abstract

The authors report a unique case of transient amaurosis occurring every time the patient flew in a jet plane and frequently when he drove up a mountain. X-ray examination showed dysplasia of the sphenoidal sinus and optic canals. The pathogenesis and the treatment of the amaurosis is discussed.

Entities:  

Mesh：

Year:  1977        PMID： 830808     DOI： 10.3171/jns.1977.46.1.0111

Source DB:  PubMed          Journal:  J Neurosurg        ISSN： 0022-3085            Impact factor:   5.115


  6 in total

1.  Vascular compressive optic neuropathy caused by hypertensive intracranial ophthalmic artery.

Authors:  Fumihito Hikage; Masato Hashimoto; Hiroshi Ohguro
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

2.  Temporary unilateral amaurosis with pneumosinus dilatans of the sphenoid sinus.

Authors:  E Bachor; R Weber; G Kahle; W Draf
Journal:  Skull Base Surg       Date:  1994

3.  Sphenoid pneumoceles cause episodic pressure-related blindness.

Authors:  M M Hanasono; A M Norbash; K Shepard; D J Terris
Journal:  West J Med       Date:  1998-11

Review 4.  Pneumosinus dilatans of the maxillary sinus: a case report and review of the literature.

Authors:  Matteo Trimarchi; Davide Lombardi; Davide Tomenzoli; Davide Farina; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-03-18       Impact factor: 2.503

5.  Sphenoid pneumosinus dilatans. A sign of meningioma originating in the optic canal.

Authors:  L W Hirst; N R Miller; F J Hodges; J J Corbett; S Thomspson
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

6.  Pneumosinus dilatans of the sphenoid and visual loss: when should the optic nerve be decompressed?

Authors:  Gilles Danassegarane; Maxime Bretonnier; Julien Tinois; Maïa Proisy; Laurent Riffaud
Journal:  Childs Nerv Syst       Date:  2020-11-03       Impact factor: 1.475
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.